GlassScriptPhysician profile
Danielle Noce Demkovitz
NPI 1528714664
$5,174.92
in general payments reported to CMS, 2019-2025
35 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,014 · 2023: $1,348 · 2024: $1,609 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,161.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $633.73 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $473.53 | 2023-2025 | Lifevest |
| Novo Nordisk INC | $436.61 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $380.79 | 2022-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $355.83 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $307.02 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $259.97 | 2022-2024 | |
| Boston Scientific Corporation | $256.90 | 2022-2024 | Watchman Access System, Watchman Flx, Watchman |
| Abiomed | $225.68 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $195.34 | 2022-2025 | Farxiga |
| Cvrx, INC. | $178.85 | 2024-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $148.20 | 2022-2024 | Xarelto |
| Scpharmaceuticals INC. | $118.17 | 2023-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $104.24 | 2022-2023 | Arcalyst |
| Irhythm Technologies, INC. | $99.85 | 2024 | Zio Xt Patch, Zio Monitor |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Demkovitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.